Results for tag: "Cuvitru"

Cuvitru is a brand of immune disorder drugs used to treat primary immunodeficiency diseases (PIDDs). It is a subcutaneous immunoglobulin (SCIG) therapy, which is a form of immunotherapy that helps to replace or supplement the body's natural antibodies. Cuvitru is designed to provide a more convenient and effective treatment option for patients with PIDDs. It is administered through a subcutaneous injection, which is less painful and more convenient than intravenous infusions. Cuvitru is also designed to provide a more consistent and predictable dosing schedule, which can help to improve patient outcomes. The Cuvitru market is composed of a variety of companies that produce and distribute the drug. These companies include CSL Behring, Grifols, Kedrion, Octapharma, and Shire. Each of these companies produces and distributes Cuvitru in different countries around the world. Additionally, there are a number of specialty pharmacies that provide Cuvitru to patients in need. Show Less Read more